Female 63 years

Right renal mass ?renal cell carcinoma. She had a partial left adrenalectomy abroad (details are not known) where the ultrasound report suggested liver mass with a possibility of liver metastastasis. The CT scan performed here showed benign cysts of liver and an incidental right renal mass.



Specimen: Right renal tissue.

Macro: A portion of renal tissue measuring 2.5x2x1.5cm. it contains a pale nodule measuring 1.5cm in maximum dimension with a uniformly pale cut surface and close to the re-section margin.

Immunohistochemistry:
Positive for SMA and HMB45 and patchy positivity for Pan M (melanA/HMB45 cocktail).

Female 69 years

Renal tumour.



Specimen: Radical Nephrectomy.

Macro: Dark brown tumour with some cystic change and haemorrhage 58mm maximum.

Immunohistochemistry:
Positive for CD56, chromogranin and synaptophysin and vimentin. Negative for RENCA, CD10 , Ckit & CK7. Proliferation index Ki67 2-20/10hpf

Male 64 years

Asyptomatic lesion discovered on ultrasound scan. Right bladder wall lump above RUO - described on request card as "not typical of TCC".



Specimen: Bladder biopsy.

Macro: Pale tissue 8mm in maximum extent.

Immunohistochemistry:
None.

Female 77 years

New bladder tumour resected to muscle.



Specimen: Bladder (TURBT).

Macro: Chippings weighing 4g.

Immunohistochemistry:
None.

Male 9 years

Lymphodema of genitals ? cause. Circumcision performed. (Additional information not on request form - lymphodema since 2009, no luminal evidence of Crohn's disease.)



Specimen: Foreskin.

Macro: Two pieces of foreskin measuring 80x35x10mm in aggregate. The tissue appears oedematous, but no other abnormalities are identified. Four representatives sections taken in two cassettes with tissue remaining.

Immunohistochemistry:
None.

Male 59 years

No clinical details provided.



Specimen: Partial nephrectomy.

Macro: Partial nephrectomy specimen, not including renal pelvis, ureter and vascular structure with a circumscribed yellow tumour 30x20x30mm, focally close to capsular surface.

Immunohistochemistry:
CK+ve . Focal CD10+ve. CD117 -ve.

Male 65 years

Urethral lesion ?TCC.



Specimen: Urethral biopsy.

Macro: A light brown strip of tissue 35mm in length x up to 2mm in diameter and a second fragment 2mm diameter.

Immunohistochemistry:
None.

Female 59 years

Known metastatic Ca breast. Bladder mass on CT. ?Extrinsic. Resection biopsy of mass done.



Specimen: Transurethral resection of bladder tumour.

Macro: Bladder tumour chippings aggregating 32mm.

Immunohistochemistry:
ER pos. PR neg. E-cadherin pos.

Male 29 years

Nodule in lower pole of left testis, suspicious on ultrasound. Microlithiasis right testis.



Specimen: Testis.

Macro: Nodule in lower pole of left testis, 14mm diameter, uniformed cream coloured cut surface.

Immunohistochemistry:
None.

Male 42 years

Excision of excess penile skin following auto-augmentation with self injected heated vaseline.



Specimen: Penile skin.

Macro: Three pieces of skin received, the largest 50x90x27mm. The cut surface appears greasy.

Immunohistochemistry:
None.

Male 46 years

Right testicular tumour.



Specimen: Right orchidectomy.

Macro: On sectioning there is a well circumscribed firm yellow mass measuring 17x15mm.

Immunohistochemistry:
None.

Male 36 years

Right testicle and cord, U/S appearance of Testicular tumour on right side.



Specimen: R testicle and cord.

Macro: Testicle with attached spermatic cord and coverings altogether weighing 64g. The spermatic cord measurres 75mm long by up to 17mm in external diameter. The testicle externally measures 60x45x38mm. The spermatic cord upon slicing shows no focal lesion. Slicing of the testicle reveals a firm white grey circumscribed solitary nodule measuring 35x27mm across the cut surface by 30mm medio-laterally. The cut surface appears homogenous throughout with small brown foci up to 7mm across. The tumour abuts the tunica focally but appears to be confined within the testicle.

Immunohistochemistry:
Positive for CD30 and AEI/3 within the areas of embryonal carcinoma, positive for CD117 and Oct3/4 within the areas of seminoma and ITGCN, focally positive for AFP in the areas of yolk sac tumour and embryonal carcinoma, patchy postitivity for PLAP, diffuse weak positivity for HCG.